Sensitive and specific fluorescent probes for functional analysis of the three major types of Mammalian ABC transporters

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Lebedeva, Irina V ^a   Pande, Praveen ^a   Patton, Wayne F ^a  

^a ENZO Life Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER INHIBITOR; BREAST CANCER RESISTANCE PROTEIN; CALCEIN AM; CYCLOSPORIN A; DAUNORUBICIN; DOXORUBICIN; FLUORESCENT DYE; FUMITREMORGIN C; GLYCOPROTEIN P; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PHEOPHORBIDE; PHEOPHORBIDE A; PROTEIN INHIBITOR; RHODAMINE 123; UNCLASSIFIED DRUG; VERLUKAST; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; KINETICS; KOLMOGOROV SMIRNOV TEST; MEDIAN EFFECTIVE CONCENTRATION; MOLECULAR PROBE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; ANIMAL; CELL SURVIVAL; CHO CELL; CRICETULUS; DRUG ANTAGONISM; ENZYME SPECIFICITY; HAMSTER; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

MAMMALIA;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; SUBSTRATE SPECIFICITY; TETRAZOLIUM SALTS; THIAZOLES;

EID: 79960675115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022429     Document Type: Article

References (37)

1. Leonard GD, Fojo T, Bates SE, (2003) The role of ABC transporters in clinical practice. Oncologist 8: 411-424.
2. Gottesman MM, Fojo T, Bates SE, (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58.
3. Haimeur A, Conseil G, Deeley RG, Cole SP, (2004) The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 5: 21-53.
4. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, et al. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 56: 3010-3020.
5. Neyfakh AA, (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 174: 168-176.
6. Litman T, Druley TE, Stein WD, Bates SE, (2001) From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 58: 931-959.
7. Hollo Z, Homolya L, Davis CW, Sarkadi B, (1994) Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta 1191: 384-388.
8. Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM, et al. (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268: 21493-21496.
9. Liminga G, Nygren P, Larsson R, (1994) Microfluorometric evaluation of calcein acetoxymethyl ester as a probe for P-glycoprotein-mediated resistance: effects of cyclosporin A and its nonimmunosuppressive analogue SDZ PSC 833. Exp Cell Res 212: 291-296.
10. Koshiba S, An R, Saito H, Wakabayashi K, Tamura A, et al. (2008) Human ABC transporters ABCG2 (BCRP) and ABCG4. Xenobiotica 38: 863-888.
11. Litman T, Brangi M, Hudson E, Fetsch P, Abati A, et al. (2000) The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci 113(Pt 11): 2011-2021.
12. van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, et al. (2009) Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. Arthritis Rheum 60: 669-677.
13. Doyle LA, Ross DD, (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22: 7340-7358.
14. Tiberghien F, Loor F, (1996) Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay. Anticancer Drugs 7: 568-578.
15. Qadir M, O'Loughlin KL, Fricke SM, Williamson NA, Greco WR, et al. (2005) Cyclosporin A is a broad-spectrum multidrug resistance modulator. Clin Cancer Res 11: 2320-2326.
16. McCollum AK, TenEyck CJ, Stensgard B, Morlan BW, Ballman KV, et al. (2008) P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response. Cancer Res 68: 7419-7427.
17. Scharenberg CW, Harkey MA, Torok-Storb B, (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99: 507-512.
18. Gupta RS, (1988) Intrinsic multidrug resistance phenotype of Chinese hamster (rodent) cells in comparison to human cells. Biochem Biophys Res Commun 153: 598-605.
19. Ling V, Kartner N, Sudo T, Siminovitch L, Riordan JR, (1983) Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep 67: 869-874.
20. Collington GK, Hunter J, Allen CN, Simmons NL, Hirst BH, (1992) Polarized efflux of 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein from cultured epithelial cell monolayers. Biochem Pharmacol 44: 417-424.
21. Hunter J, Hirst BH, Simmons NL, (1991) Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein. Br J Cancer 64: 437-444.
22. Alvarez M, Paull K, Monks A, Hose C, Lee JS, et al. (1995) Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen. J Clin Invest 95: 2205-2214.
23. Cantz T, Nies AT, Brom M, Hofmann AF, Keppler D, (2000) MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. Am J Physiol Gastrointest Liver Physiol 278: G522-531.
24. Roelofsen H, Vos TA, Schippers IJ, Kuipers F, Koning H, et al. (1997) Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology 112: 511-521.
25. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
26. Young IT, (1977) Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25: 935-941.
27. Broxterman HJ, Lankelma J, Pinedo HM, Eekman CA, Wahrer DC, et al. (1997) Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia. Leukemia 11: 1110-1118.
28. Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Wahrer DC, et al. (1996) Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood 87: 4809-4816.
29. Sarkadi B, Homolya L, Szakacs G, Varadi A, (2006) Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 86: 1179-1236.
30. Sauna ZE, Ambudkar SV, (2007) About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work. Mol Cancer Ther 6: 13-23.
31. Minderman H, Vanhoefer U, Toth K, Yin MB, Minderman MD, et al. (1996) DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux. Cytometry 25: 14-20.
32. Robey RW, Steadman K, Polgar O, Morisaki K, Blayney M, et al. (2004) Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res 64: 1242-1246.
33. Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, et al. (1999) Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 91: 429-433.
34. Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM, (1989) Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. Cancer Res 49: 4542-4549.
35. Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM, (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 60: 47-50.
36. Hollo Z, Homolya L, Hegedus T, Sarkadi B, (1996) Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Lett 383: 99-104.
37. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, et al. (2010) Membrane transporters in drug development. Nat Rev Drug Discov 9: 215-236.